Cargando…

Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study

BACKGROUND: The extent of resection required in advanced gallbladder cancer is controversial. We aimed to describe the management and outcomes in patients with resected stage T2 and T3 gallbladder cancer. METHODS: In this population-based study, all T2 and T3 gallbladder cancer cases from Jan. 1, 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Tharmalingam, Senthuran, Flemming, Jennifer, Richardson, Harriet, Hurlbut, David, Cleary, Sean, Nanji, Sulaiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759294/
https://www.ncbi.nlm.nih.gov/pubmed/35017185
http://dx.doi.org/10.1503/cjs.019719
_version_ 1784633081049645056
author Tharmalingam, Senthuran
Flemming, Jennifer
Richardson, Harriet
Hurlbut, David
Cleary, Sean
Nanji, Sulaiman
author_facet Tharmalingam, Senthuran
Flemming, Jennifer
Richardson, Harriet
Hurlbut, David
Cleary, Sean
Nanji, Sulaiman
author_sort Tharmalingam, Senthuran
collection PubMed
description BACKGROUND: The extent of resection required in advanced gallbladder cancer is controversial. We aimed to describe the management and outcomes in patients with resected stage T2 and T3 gallbladder cancer. METHODS: In this population-based study, all T2 and T3 gallbladder cancer cases from Jan. 1, 2002, to Mar. 31, 2012, were identified from the Ontario Cancer Registry; pathology reports were linked and abstracted. The type of resection was classified as extended (cholecystectomy + liver resection, with or without bile duct resection) or simple (cholecystectomy only). We used Kaplan–Meier survival analysis to model time to death and evaluated factors associated with overall survival using the Cox proportional hazards regression model. RESULTS: A total of 370 patients were included, 232 with T2 disease and 138 with T3 disease. The proportions who underwent extended resection were 24.1% (56/232) and 37.0% (51/138), respectively. The unadjusted 5-year overall survival rates for simple and extended resection were 39.7% and 49.5%, respectively, for T2 disease (p = 0.03), and 13.5% and 22.8%, respectively, for T3 disease (p = 0.05). In adjusted analysis, extended resection significantly improved overall survival among patients with T2 disease (hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.30–0.97), whereas higher grade of differentiation, presence of lymphovascular invasion and positive lymph nodes led to worse survival. Extended resection was not associated with improved survival in the T3 group; however, in subgroup analysis stratified by lymph node status, a trend toward improved overall survival with extended resection was seen in node-negative patients (HR 0.20, 95% CI 0.03–1.06). CONCLUSION: Extended resection improved overall survival in T2 disease regardless of nodal status but appeared most beneficial in node-negative T3 disease. The finding that extended resection was offered only to a small proportion of eligible patients highlights the need for improved knowledge translation at national surgical meetings.
format Online
Article
Text
id pubmed-8759294
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-87592942022-01-17 Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study Tharmalingam, Senthuran Flemming, Jennifer Richardson, Harriet Hurlbut, David Cleary, Sean Nanji, Sulaiman Can J Surg Research BACKGROUND: The extent of resection required in advanced gallbladder cancer is controversial. We aimed to describe the management and outcomes in patients with resected stage T2 and T3 gallbladder cancer. METHODS: In this population-based study, all T2 and T3 gallbladder cancer cases from Jan. 1, 2002, to Mar. 31, 2012, were identified from the Ontario Cancer Registry; pathology reports were linked and abstracted. The type of resection was classified as extended (cholecystectomy + liver resection, with or without bile duct resection) or simple (cholecystectomy only). We used Kaplan–Meier survival analysis to model time to death and evaluated factors associated with overall survival using the Cox proportional hazards regression model. RESULTS: A total of 370 patients were included, 232 with T2 disease and 138 with T3 disease. The proportions who underwent extended resection were 24.1% (56/232) and 37.0% (51/138), respectively. The unadjusted 5-year overall survival rates for simple and extended resection were 39.7% and 49.5%, respectively, for T2 disease (p = 0.03), and 13.5% and 22.8%, respectively, for T3 disease (p = 0.05). In adjusted analysis, extended resection significantly improved overall survival among patients with T2 disease (hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.30–0.97), whereas higher grade of differentiation, presence of lymphovascular invasion and positive lymph nodes led to worse survival. Extended resection was not associated with improved survival in the T3 group; however, in subgroup analysis stratified by lymph node status, a trend toward improved overall survival with extended resection was seen in node-negative patients (HR 0.20, 95% CI 0.03–1.06). CONCLUSION: Extended resection improved overall survival in T2 disease regardless of nodal status but appeared most beneficial in node-negative T3 disease. The finding that extended resection was offered only to a small proportion of eligible patients highlights the need for improved knowledge translation at national surgical meetings. CMA Impact Inc. 2022-01-11 /pmc/articles/PMC8759294/ /pubmed/35017185 http://dx.doi.org/10.1503/cjs.019719 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Tharmalingam, Senthuran
Flemming, Jennifer
Richardson, Harriet
Hurlbut, David
Cleary, Sean
Nanji, Sulaiman
Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title_full Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title_fullStr Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title_full_unstemmed Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title_short Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study
title_sort surgical practice patterns and outcomes in t2 and t3 gallbladder cancer: a population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759294/
https://www.ncbi.nlm.nih.gov/pubmed/35017185
http://dx.doi.org/10.1503/cjs.019719
work_keys_str_mv AT tharmalingamsenthuran surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy
AT flemmingjennifer surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy
AT richardsonharriet surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy
AT hurlbutdavid surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy
AT clearysean surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy
AT nanjisulaiman surgicalpracticepatternsandoutcomesint2andt3gallbladdercancerapopulationbasedstudy